Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep

• Published in: American journal of physiology. Heart and circulatory physiology Vol. 298; no. 1; p. H179
• Main Authors: Sadowska, Grazyna B, Malaeb, Shadi N, Stonestreet, Barbara S
• Format: Journal Article
• Language: English
• Published: United States 01-01-2010
• Subjects: Animals; Blood-Brain Barrier - drug effects; Blotting, Western; Brain Chemistry - drug effects; Cell Line; Densitometry; Dexamethasone - pharmacology; Female; Fetus - metabolism; Glucocorticoids - pharmacology; Nerve Tissue Proteins - drug effects; Permeability - drug effects; Pregnancy; Regression Analysis; Sheep; Spinal Cord - metabolism; Tight Junctions - drug effects; Tight Junctions - metabolism
• DOI: 10.1152/ajpheart.00828.2009
• EISSN: 1522-1539

We examined the expression of tight junction (TJ) proteins in the cerebral cortex, cerebellum, and spinal cord of fetuses after maternal treatment with single and multiple courses of dexamethasone. Ewes received either single courses of four 6-mg dexamethasone or placebo injections every 12 h for 48 h between 104 and 107 days or the same treatment once a week between 76-78 and 104-107 days of gestation. TJ protein expression was determined by Western immunoblot analysis on tissue harvested at 105-108 days of gestation. Blood-brain barrier permeability has been previously quantified with the blood-to-brain transfer constant (K(i)) with alpha-aminoisobutyric acid (39). After a single course of dexamethasone, claudin-5 increased (P < 0.05) in the cerebral cortex, occludin and claudin-1 increased in the cerebellum, and occludin increased in the spinal cord. After multiple dexamethasone courses, occludin and zonula occludens (ZO)-1 increased in the cerebral cortex, and occludin and claudin-1 increased in the cerebellum. Junctional adhesion molecule-A and ZO-2 expressions did not change. Linear regression comparing K(i) to TJ proteins showed inverse correlations with claudin-1 and claudin-5 in the cerebral cortex after a single course and ZO-2 in the spinal cord after multiple courses and direct correlations with ZO-1 in the cerebellum and spinal cord after multiple courses. We conclude that maternal glucocorticoid treatment increases the expression of specific TJ proteins in vivo, patterns of TJ protein expression vary after exposure to single and multiple glucocorticoid courses, and decreases in blood-brain barrier permeability are associated with increases in claudin-1, claudin-5, and ZO-2 expression and decreases in ZO-1 expression. In utero glucocorticoid exposure alters the molecular composition of the barrier and affects fetal blood-brain barrier function.